Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT01650259 · COMPLETED

Trial details

NCT number: NCT01650259
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2012-07-23
Primary completion: 2017-09-05
Enrollment: 4876

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.